Founded in 2008, Inveready Technology Investment Group is a venture capital investment firm based in Barcelona, Spain. The firm seeks to invest in the technology, biotechnology, clean-tech, information technology, and healthcare sectors.
Inveready Technology Investment Group invest through 4 verticals (Venture Capital in Digital Technology, Venture Capital in Life Sciences, Venture Debt and Hybrid Financing for quoted companies in growth markets), with over €330 million of assets under management.
Inveready Technology Investment Group has made investments in Ability Pharmaceuticals, VIVEbiotech, VOLAVA, ProntoPiso, Foxtenn, Zinklar, HETIKUS, Spiral Therapeutics, Clerhp and Beezy.
They exited their investments in Minoryx Therapeutics, AVX Pharma, 3scale, Sweetspot, Agile Content, Edesa Biotech, GIGAS, Respiro, iSalud.com, eyeOS and MyTwinPlace.
Invested in
Patents
Funding Rounds Participated In
Further reading
Documentaries, videos and podcasts
References
Organization
Venture capital firm
CompanyCompany attributes
Biotechnology
Madrid
San Sebastián
BarcelonaCategories
Related Topics
Contributors
- 1
Aleksander Holm
Interested in understanding the world we live in. - 2
Jed Christiansen
Director of Product and Data at Golden || Founder - Seed-DB. - 3
Carla Faraguna
Golden People and Operations. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Katrina-Kay Alaimo
Data Wizard @ Golden | PhD Classics | Language Enthusiast - 6
Henry Ogolla
Passionate about reading and writing.